Summary
The product Semaglutide, from an Asteroid Biotech manufacturer, underwent independent testing to verify its authenticity and purity. The sample, associated with Task Number #51797, was submitted by asteroidbiotech@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control.
The analysis confirmed the presence of Semaglutide, with a measured concentration of 5.49 mg and a purity of 99.574%.
The testing process began on 16 October 2024, with the sample received on 31 October 2024, and analysis completed on 4 November 2024. While the results confirm the presence and high purity of Semaglutide, manufacturer-submitted samples should always be evaluated critically. Independent third-party testing remains crucial for ensuring consistent quality across batches.
Detailed Report
Product Overview
- Manufacturer: Asteroid Biotech
- Product Name: Semaglutide
- Active Ingredient: Semaglutide
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Peptide vial
Testing Details
- Task Number: #51797
- Testing Ordered: 16 October 2024
- Sample Received: 31 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Asteroid Biotech (manufacturer)
- Analysis Paid For By: Asteroid Biotech (manufacturer)
Testing Results
- Measured Concentration: 5.49 mg
- Purity: 99.574%
Verification Details
- Verification URL: https://janoshik.com/tests/51797_ETFCN64K91WV
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the presence and high purity of Semaglutide, but due diligence is needed. Manufacturer-submitted samples can be selectively chosen to pass testing, which may not accurately represent commercially available batches. Janoshik Analytical is a respected independent testing lab, but further verification through third-party analysis is always recommended.
Conclusion
The analysis confirms that Semaglutide contains 5.49 mg of the active ingredient with 99.574% purity. While the results are promising, further independent testing across different batches is necessary to ensure consistency. This report is published to support educational and harm reduction efforts, helping consumers make informed decisions regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
